Your browser doesn't support javascript.
loading
Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy.
Bolze, Pierre-Adrien; Lopez, Jonathan; Allias, Fabienne; Hajri, Touria; Patrier, Sophie; Devouassoux-Shisheboran, Mojgan; Massardier, Jérôme; You, Benoit; Golfier, François; Mallet, François.
Afiliación
  • Bolze PA; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Department of Gynecological Surgery and Oncology, Obstetrics, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69
  • Lopez J; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Plateforme de Recherche de Transfert en Oncologie, Department of Biochemistry and Molecular Biology, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; Faculté de Médecine Lyon Est, Lyon, France; Centre de Recherche
  • Allias F; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Department of Pathology, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France.
  • Hajri T; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France.
  • Patrier S; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; Department of Pathology, University Hospital of Rouen, F-76031 Rouen Cedex, France.
  • Devouassoux-Shisheboran M; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Department of Pathology, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France.
  • Massardier J; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; University of Lyon 1, University Hospital Femme Mere Enfant, Department of Obstetrics and Gynecology, 51, boulevard Pinel, 69500 Bron, France.
  • You B; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Medical Oncology Department, Investigational Center for Treatments in Oncology and Hematology
  • Golfier F; University of Lyon 1, Hospices Civils de Lyon, University Hospital Lyon Sud, Department of Gynecological Surgery and Oncology, Obstetrics, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 chemin du grand Revoyet, 69
  • Mallet F; Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, 165 chemin du grand Revoyet, 69495 Pierre Bénite, France; Medical Diagnostic Discovery Department (MD3), bioMérieux S.A., Marcy l'Etoile, France; Joint Research Unit Hospices Civils de Lyon-bioMérieux
Gynecol Oncol ; 158(3): 785-793, 2020 09.
Article en En | MEDLINE | ID: mdl-32513563

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Coriocarcinoma / Mola Hidatiforme / Antígenos HLA-G Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Coriocarcinoma / Mola Hidatiforme / Antígenos HLA-G Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article